RESVERATROL INHIBITS EXPRESSION OF CANCER-SPECIFIC PENTOSE PHOSPHATE PATHWAY ENZYME TKTL1

Bhupender Kumar(Alexandra Hospital)
Asian Journal of Pharmaceutical and Clinical Research
June 7, 2018
10.22159/ajpcr.2018.v11i6.25021
Cited by 1

Related Papers

Visceral fat: A key mediator of NAFLD development and progression
|Human Nutrition & Metabolism|2023|58
Deciphering the role of aberrant DNA methylation in NAFLD and NASH
|Heliyon|2022|31
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
|Journal of Cellular Biochemistry|2022|11